Traub Ariana, Sharma Apoorva, Gongora M Carolina
Emory University School of Medicine, Emory University Atlanta, GA.
Department of Internal Medicine, Emory University Atlanta, GA.
US Cardiol. 2024 Feb 12;18:e03. doi: 10.15420/usc.2023.01. eCollection 2024.
Maternal mortality continues to increase in the US, with hypertensive disorders of pregnancy (HDP) remaining one of the leading causes of morbidity and mortality. In this article, the definition, classification, and pathophysiology of the different forms of HDP, current management of these disorders, disparities in prevalence and management of these conditions, and potential strategies to improve HDP outcomes and combat disparities to reduce maternal morbidity and mortality are reviewed. Current management favors a more conservative approach to treating mild chronic hypertension (140-160/90-100 mmHg) in pregnancy. However, recent data suggests active treatment of mild chronic hypertension improves maternofetal pregnancy related outcomes.
在美国,孕产妇死亡率持续上升,妊娠高血压疾病(HDP)仍然是发病和死亡的主要原因之一。本文回顾了不同形式HDP的定义、分类和病理生理学,这些疾病的当前管理方法,这些病症在患病率和管理方面的差异,以及改善HDP结局和消除差异以降低孕产妇发病率和死亡率的潜在策略。目前的管理倾向于对孕期轻度慢性高血压(140 - 160/90 - 100 mmHg)采取更保守的治疗方法。然而,最近的数据表明,积极治疗轻度慢性高血压可改善母婴妊娠相关结局。